Abstract: The present invention relates to the use of a nutritional composition having a low amount of protein, such as less than 1.8 g/100 kcal for administration to infants of non-obese and non-overweight mothers so as to reduce the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.

Abstract: The present invention relates to the use of a nutritional composition having a low amount of protein, such as less than 1.8 g/100 kcal for administration to infants of non-obese and non-overweight mothers so as to reduce the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.

Abstract: The present invention relates to a nutritional composition such as an infant formula comprising phospholipids in an amount of at least 300 mg/L. Bioactive compounds may preferably be added to the nutritional composition. The present invention also relates to use of said nutritional composition by feeding an infant with the nutritional composition for reducing the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.

Abstract: The present invention relates to the use of a nutritional composition having a low amount of protein, such as less than 1.8 g/100 kcal for administration to infants of non-obese and non-overweight mothers so as to reduce the risk of developing metabolic syndrome, increased weight gain, increased fat deposition, overweight, obesity, insulin resistance, glucose intolerance or diabetes mellitus later in said infant's life.

Abstract: The present invention proposes a dispensing container (1) A for probiotics (2) in a viscous or liquid carrier (3), the probiotics (2) having a higher specific weight than the viscous or liquid carrier (3), wherein the container (1) comprises a reservoir (4) for holding the carrier (3) and a dispensing head (5) being in fluid connection with the reservoir (4), the dispensing head (5) comprising at least one outlet (6), wherein the concentration of the probiotics (2) decreases from the outlet (6) of the dispensing head (5) towards a bottom portion (1a) of the reservoir (1).

Abstract: The use of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longumin the manufacture of a medicament or therapeutic nutritional composition for administration to an infant during at least the first three months of life for the long-term prophylaxis of diarrhea in infants and young children.

Abstract: The invention relates to a suction device (1, 10, 20, 30) comprising a suction portion (3, 13, 23, 33) to be sucked by a user'mouth, characterized in that probiotics (7, 17, 27, 37) are adhered to or immobilized on the outer surface of the suction device (1, 10, 20, 30) such that probiotics (7, 17, 27, 37) are segregated from the outer surface by external factors when the suction device (1, 10, 20, 30) is sucked.

Abstract: The invention relates to a feeding device (1, 1?, 1?) having a hollow form, the feeding device (1, 1?, 1?) comprising: an inlet portion (2, 2?, 2?) having an inlet (4, 4?) for entering nutrition (13), and a suction portion (3, 3?, 3?) for sucking the nutrition (13) through the inlet (4, 4?) into the feeding device (1, 1?, 1?), wherein the suction portion (3, 3?, 3?) comprises at least one opening (5, 5?, 5?) for dispensing the sucked nutrition (13), wherein the inner surface (6, 6?, 6?) of the feeding device (1, 1?, 1?) confines a flow path (P, P?, P?) for the nutrition (13), and wherein the feeding device (1, 1?, 1?) is at least partially deformable. The feeding device is characterized in that a nutritional additive (7, 7?, 7?) is adhered to the flow path confining inner surface (6, 6?, 6?) of the feeding device (1, 1?, 1?) such that the nutritional additive (7, 7?, 7?) is mechanically segregated from the inner surface (6, 6?, 6?) when the feeding device (1, 1?, 1?) is deformed.

Abstract: The present invention proposes a dispensing container (1) A for probiotics (2) in a viscous or liquid carrier (3), the probiotics (2) having a higher specific weight than the viscous or liquid carrier (3), wherein the container (1) comprises a reservoir (4) for holding the carrier (3) and a dispensing head (5) being in fluid connection with the reservoir (4), the dispensing head (5) comprising at least one outlet (6), wherein the concentration of the probiotics (2) decreases from the outlet (6) of the dispensing head (5) towards a bottom portion (1a) of the reservoir (1).

Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.

Abstract: A nutritional composition for the management of regurgitation in infants which composition includes which composition includes a protein source consisting essentially of partially hydrolysed proteins, a lipid source and a carbohydrate source comprising a starch selected from cereal starch or potato starch wherein the starch amounts to between 18 to 25% of the nutritional composition on a dry weight basis.

Abstract: The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for reducing the risk of subsequent development of allergy in infants delivered by caesarean section.

Abstract: The use of a probiotic Lactobacillus rhamnosus and a probiotic Bifidobacterium longumin the manufacture of a medicament or therapeutic nutritional composition for administration to an infant during at least the first three months of life for the long-term prophylaxis of diarrhoea in infants and young children.

Abstract: The use of Bifidobacterium lactis CNCM 1-3446 in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section is disclosed.

Abstract: The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for preventing or treating diarrhoea in infants delivered by caesarean section.

Abstract: The use of a probiotic strain of Lactobacillus rhamnosus and an oligosaccharide mixture which comprises 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising GalNAc?1,3Gal?1,4Glc and Gal?1,6GalNAc?1,3Gal?1,4Glc, 20-90 wt % of at least one neutral oligosaccharide selected from the group comprising Gal?1,6Gal, Gal?1,6Gal?1,4Glc Gal?1,6Gal?1,6Glc, Gal?1,3Gal?1,3Glc, Gal? 1,3Gal? 1,4GIc, Gal? 1,6Gal? 1,6Gal? 1,4GIc, Gal? 1,6Gal? 1,3Gal? 1,4GIc Gal?1,3Gal?1,6Gal?1,4Glc and Gal?1,3Gal?1,3Gal?1, 4GIc and 5-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAc?2,3Gal?1,4GIc and NeuAc?2,6Gal?1,4Glc in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by caesarean section is disclosed.

Abstract: The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 102 and 105 cfu/g of dry formula. The invention further extends to the use of such an infant formula to modulate the immune system of a neonatal infant to promote the development in the first few weeks of the life of the infant of a beneficial intestinal microbiota comparable with that found in breast fed babies as well as to promote the maturation of the immune system of a neonatal infant in the first few weeks of life.